Answers are grounded in this paper and cite their sources.
We aimed to investigate the use of free glycosaminoglycan profiles (GAGomes) and cfDNA in plasma to differentiate between lung cancer and benign lung disease, in a cohort of 113 patients initially suspected of lung cancer. GAGomes were analyzed in all samples using the MIRAM
No takes yet. Share an insight, caveat, or question.
Qvick et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: